N-cadherin regulates mammary tumor cell migration through Akt3 suppression

Oncogene

Volumn 32, Issue 4, 2013, Pages 422-430

  Chung, S ^a   Yao, J ^a   Suyama, K ^a   Bajaj, S ^a   Qian, X ^a   Loudig, O D ^a   Eugenin, E A ^a   Phillips, G R ^b   Hazan, R B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

adhesion; Akt isoforms; Akt3; breast cancer; motility

Indexed keywords

NERVE CELL ADHESION MOLECULE; PROTEIN AKT3; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST TUMOR; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; METASTASIS; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; TUMOR CELL;

ANIMALS; CADHERINS; CELL GROWTH PROCESSES; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HEK293 CELLS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MCF-7 CELLS; MICE; NEOPLASM METASTASIS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, FIBROBLAST GROWTH FACTOR;

EID: 84873058198     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.65     Document Type: Article

References (27)

1. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-572.
2. Wheelock MJ, Johnson KR. Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 2003; 19: 207-235.
3. Wheelock MJ, Johnson KR. Cadherin-mediated cellular signaling. Curr Opin Cell Biol 2003; 15: 509-514.
4. Cavallaro U. N-cadherin as an invasion promoter: A novel target for antitumor therapy? Curr Opin Investig Drugs 2004; 5: 1274-1278.
5. Hazan RB, Kang L, Whooley BP, Borgen PI. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 1997; 4: 399-411.
6. Nagi C, Guttman M, Jaffer S, Qiao R, Keren R, Triana A et al. N-cadherin expression in breast cancer: Correlation with an aggressive histologic variant-invasive micropapillary carcinoma. Breast Cancer Res Treat 2005; 94: 225-235.
7. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999; 147: 631-644.
8. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000; 148: 779-790.
9. Suyama K, Shapiro I, Guttman M, Hazan RB. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2002; 2: 301-314.
10. Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, Shan W et al. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res 2007; 67: 3106-3116.
11. Chin YR, Toker A. Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. Cell Signal 2009; 21: 470-476.
12. Dillon RL, Muller WJ. Distinct biological roles for the Akt family in mammary tumor progression. Cancer Res 2010; 70: 4260-4264.
13. Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelialmesenchymal transition. J Cell Biol 2005; 171: 1023-1034.
14. Iliopoulos D, Polytarchou C, Hatziapostolou M, Kottakis F, Maroulakou IG, Struhl K et al. MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci Signal 2009; 2: ra62.
15. Bellacosa A, Kumar CC, Di Cristofano A, Testa Jr. Activation of AKT kinases in cancer: Implications for therapeutic targeting. Adv Cancer Res 2005; 94: 29-86.
16. Agiostratidou G, Li M, Suyama K, Badano I, Keren R, Chung S et al. Loss of retinal cadherin facilitates mammary tumor progression and metastasis. Cancer Res 2009; 69: 5030-5038.
17. Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, Lu GH et al. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J 1998; 17: 5896-5904.
18. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I et al. A lipidanchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 1997; 89: 693-702.
19. Roccaro AM, Sacco A, Thompson B, Leleu X, Azab AK, Azab F et al. MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood 2009; 113: 6669-6680.
20. Nogueira C, Kim KH, Sung H, Paraiso KH, Dannenberg JH, Bosenberg M et al. Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis. Oncogene 2010; 29: 6222-6232.
21. Toker A, Yoeli-Lerner M. Akt signaling and cancer: Surviving but not moving on. Cancer Res 2006; 66: 3963-3966.
22. Brognard J, Sierecki E, Gao T, Newton AC. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 2007; 25: 917-931.
23. Chin YR, Toker A. The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration. Mol Cell 2010; 38: 333-344.
24. Maroulakou IG, Oemler W, Naber SP, Tsichlis PN. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res 2007; 67: 167-177.
25. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol Cell Biol 1992; 12: 954-961.
26. Agiostratidou G, Hulit J, Phillips GR, Hazan RB. Differential cadherin expression: Potential markers for epithelial to mesenchymal transformation during tumor progression. J Mammary Gland Biol Neoplasia 2007; 12: 127-133.
27. Debnath J, Walker SJ, Brugge JS. Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner. J Cell Biol 2003; 163: 315-326.